Literature DB >> 8767687

[Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology].

A L Balaton1, J M Coindre, F Collin, F Ettore, M Fiche, J Jacquemier, V Le Doussal, A M Mandard, M C Mathieu, C Migeon, J Simony-Lafontaine, I Treilleux, V Verriele, M O Vilain, B Zafrani.   

Abstract

These recommendations regard the immunohistochemical evaluation of estrogen and progesterone receptors in paraffin sections of breast cancers. All the components of the procedure are dealt with: fixation, antigen retrieval, antibodies, controls, analysis and interpretation of immunostaining, report and quality assurance parameters. The purpose of these guidelines is to serve as a basis for standardization of techniques and results and to improve quality control.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8767687

Source DB:  PubMed          Journal:  Ann Pathol        ISSN: 0242-6498            Impact factor:   0.407


  10 in total

1.  Should BRCA2 mutation carriers avoid neoadjuvant chemotherapy?

Authors:  J Raphael; C Mazouni; O Caron; M Ferchiou; S Delaloge
Journal:  Med Oncol       Date:  2014-01-22       Impact factor: 3.064

2.  Immunohistochemistry as an important tool in biomarkers detection and clinical practice.

Authors:  Leandro Luongo de Matos; Damila Cristina Trufelli; Maria Graciela Luongo de Matos; Maria Aparecida da Silva Pinhal
Journal:  Biomark Insights       Date:  2010-02-09

3.  Discordances in estrogen receptor status, progesterone receptor status, and HER2 status between primary breast cancer and metastasis.

Authors:  Elsa Curtit; Virginie Nerich; Laura Mansi; Loic Chaigneau; Laurent Cals; Cristian Villanueva; Fernando Bazan; Philippe Montcuquet; Nathalie Meneveau; Sophie Perrin; Marie-Paule Algros; Xavier Pivot
Journal:  Oncologist       Date:  2013-05-30

4.  Tumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinoma.

Authors:  Jean-Christophe Tille; André F Vieira; Caroline Saint-Martin; Lounes Djerroudi; Laëtitia Furhmann; Francois-Clement Bidard; Youlia Kirova; Anne Tardivon; Fabien Reyal; Matthieu Carton; Anne Vincent-Salomon
Journal:  Mod Pathol       Date:  2020-05-13       Impact factor: 7.842

5.  Respective prognostic value of genomic grade and histological proliferation markers in early stage (pN0) breast carcinoma.

Authors:  Fabien Reyal; Marc A Bollet; Martial Caly; David Gentien; Sabrina Carpentier; Hélène Peyro-Saint-Paul; Jean-Yves Pierga; Paul Cottu; Véronique Dieras; Brigitte Sigal-Zafrani; Anne Vincent-Salomon; Xavier Sastre-Garau
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

6.  Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma.

Authors:  C Daveau; S Baulies; M Lalloum; M Bollet; B Sigal-Zafrani; X Sastre; A Vincent-Salomon; A Tardivon; F Thibault; J Y Pierga; P Cottu; M P Sablin; R Rouzier; C Malhaire; P Mallon; F Reyal
Journal:  Br J Cancer       Date:  2014-04-08       Impact factor: 7.640

7.  Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy.

Authors:  S Baulies; L Belin; P Mallon; C Senechal; J-Y Pierga; P Cottu; M-P Sablin; X Sastre; B Asselain; R Rouzier; F Reyal
Journal:  Br J Cancer       Date:  2015-06-16       Impact factor: 7.640

8.  Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma.

Authors:  L Rossi; E Laas; P Mallon; A Vincent-Salomon; J-M Guinebretiere; F Lerebours; R Rouzier; J-Y Pierga; F Reyal
Journal:  Br J Cancer       Date:  2015-09-17       Impact factor: 7.640

9.  Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment.

Authors:  Marc A Bollet; Alexia Savignoni; Leanne De Koning; Carine Tran-Perennou; Catherine Barbaroux; Armelle Degeorges; Brigitte Sigal-Zafrani; Geneviève Almouzni; Paul Cottu; Rémy Salmon; Nicolas Servant; Alain Fourquet; Patricia de Cremoux
Journal:  Breast Cancer Res       Date:  2009-07-28       Impact factor: 6.466

10.  Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma.

Authors:  Fabien Reyal; David Hajage; Alexia Savignoni; Jean-Guillaume Feron; Marc Andrew Bollet; Youlia Kirova; Alain Fourquet; Jean-Yves Pierga; Paul Cottu; Veronique Dieras; Virginie Fourchotte; Fatima Laki; Severine Alran; Bernard Asselain; Anne Vincent-Salomon; Brigitte Sigal-Zafrani; Xavier Sastre-Garau
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.